BioTissue Holdings Inc

FDA inspection history in Doral, Florida, 2026

1
Form 483

Every document, by year

  • Form 483

2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2026One Form 483, at Doral, Florida.

Cited most

Across all BioTissue Holdings observations on file

  • ISO 13485:2016 Clause 8.2.1
    1
  • ISO 13485:2016 Clause 8.5.2
    1
  • 21 CFR 803.50(a)(1)
    If I am a manufacturer, what reporting requirements apply to me?
    1

The complete BioTissue Holdings file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2026-02-18483 Form 483$99

Investigators on these documents

Ronald Ifraimov (1)

FEI number 3009809074 · most recent document Feb 18, 2026

About BioTissue Holdings Inc

How many FDA Form 483s has BioTissue Holdings Inc received?

FDA Intel has 1 Form 483 on file for BioTissue Holdings Inc; the most recent is dated Feb 18, 2026.

When was BioTissue Holdings Inc last inspected by FDA?

The most recent FDA inspection document on file for BioTissue Holdings Inc is a Form 483 dated Feb 18, 2026, for the site in Doral, Florida.

What did FDA cite at BioTissue Holdings Inc?

The regulations cited most in the observations on file for BioTissue Holdings Inc are ISO 13485:2016 Clause 8.2.1, 1 time; ISO 13485:2016 Clause 8.5.2, 1 time; 21 CFR 803.50(a)(1) (If I am a manufacturer, what reporting requirements apply to me?), 1 time.